Rempfer MV, Fowler CA (2018) Relationships among functional capacity, cognition, and naturalistic skill performance in people with serious mental illness. Psychiatry Res 270:453–458

Article  PubMed  Google Scholar 

Nemoto T, Uchino T, Aikawa S, Saito J, Matsumoto H, Funatogawa T, Yamaguchi T, Katagiri N, Tsujino N, Mizuno M (2019) Social anxiety and negative symptoms as the characteristics of patients with schizophrenia who show competence-performance discrepancy in social functioning. Psychiatry Clin Neurosci 73:394–399

Article  PubMed  Google Scholar 

Vrbova K, Prasko J, Cerna M, Grambal A, Jelenova D, Kamaradova D, Latalova K, Ociskova M, Sedlackova Z, Sigmundova Z (2011) The quality of life of patients suffering from schizophrenia–a comparison with healthy controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155:173

Article  PubMed  Google Scholar 

Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull 26:119–136

Article  CAS  PubMed  Google Scholar 

Cervellione KL, Burdick KE, Cottone JG, Rhinewine JP, Kumra S (2007) Neurocognitive deficits in adolescents with schizophrenia: Longitudinal stability and predictive utility for short-term functional outcome. J Am Acad Child Adolesc Psychiatry 46:867–878

Article  PubMed  Google Scholar 

Tripathi A, Kar SK, Shukla R (2018) Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies. Clin Psychopharmacol Neurosci 16:7–17

Article  PubMed  PubMed Central  Google Scholar 

Szabo S, Merikle E, Lozano-Ortega G, Powell L, Macek T, Cline S (2018) Assessing the relationship between performance on the university of california performance skills assessment (upsa) and outcomes in schizophrenia: a systematic review and evidence synthesis. Schizophr Res Treatment 2018:9075174

Article  PubMed  PubMed Central  Google Scholar 

Xia L, Yuan L, Du XD, Wang D, Wang J, Xu H, Huo L, Tian Y, Dai Q, Wei S, Wang W, Trihn TH, Alnatour OI, Chen D, Xiu M, Wang L, Yang M, Zhang XY (2020) P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of matrics consensus cognitive battery. Schizophr Res 215:105–112

Article  PubMed  Google Scholar 

Xia L, Wang D, Wang J, Xu H, Huo L, Tian Y, Dai Q, Wei S, Wang W, Zhang G, Du X, Jia Q, Zhu X, Wang L, Tang W, Zhang XY (2020) Association of cognitive and p50 suppression deficits in chronic patients with schizophrenia. Clin Neurophysiol 131:725–733

Article  PubMed  Google Scholar 

Proshin AT (2022) Comparative analysis of dopaminergic and cholinergic mechanisms of sensory and sensorimotor gating in healthy individuals and in patients with schizophrenia. Front Behav Neurosci 16:887312

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei Y, Ozdemir RA, Perez MA (2018) Gating of sensory input at subcortical and cortical levels during grasping in humans. J Neurosci 38:7237–7247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freedman R, Olsen-Dufour AM, Olincy A, Consortium on the Genetics of S (2020) P50 inhibitory sensory gating in schizophrenia: analysis of recent studies. Schizophr Res 218:93–98

Article  PubMed  PubMed Central  Google Scholar 

Wang DM, Xia LY, Zhou HX, Tian Y, Dai QL, Xiu MH, Chen DC, Wang L, Zhang XY (2023) Smoking affects the association between cognitive impairment and p50 inhibition defects in patients with chronic schizophrenia: a case-control study. Asian J Psychiatr 79:103391

Article  PubMed  Google Scholar 

Zhu XL, Tan SP, Wang ZR, Zhang JG, Li D, Fan FM, Zhao YL, Zou YZ, Tan YL, Yang F, Zhang XY (2017) P50 suppression deficits and psychopathology in han chinese patients with schizophrenia. Neurosci Lett 653:346–350

Article  CAS  PubMed  Google Scholar 

Schubring D, Popov T, Miller GA, Rockstroh B (2018) Consistency of abnormal sensory gating in first-admission and chronic schizophrenia across quantification methods. Psychophysiology. https://doi.org/10.1111/psyp.13006

Article  PubMed  Google Scholar 

Xia L, Liu L, Hong X, Wang D, Wei G, Wang J, Zhou H, Xu H, Tian Y, Dai Q, Wu HE, Chang C, Wang L, Kosten TR, Zhang XY (2020) One-day tropisetron treatment improves cognitive deficits and p50 inhibition deficits in schizophrenia. Neuropsychopharmacology 45:1362–1368

Article  PubMed  PubMed Central  Google Scholar 

Chang Q, Liu M, Tian Q, Wang H, Luo Y, Zhang J, Wang C (2019) Eeg-based brain functional connectivity in first-episode schizophrenia patients, ultra-high-risk individuals, and healthy controls during p50 suppression. Front Hum Neurosci 13:379

Article  PubMed  PubMed Central  Google Scholar 

Hsieh MH, Lin YT, Chien YL, Hwang TJ, Hwu HG, Liu CM, Liu CC (2019) Auditory event-related potentials in antipsychotic-free subjects with ultra-high-risk state and first-episode psychosis. Front Psychiatry 10:223

Article  PubMed  PubMed Central  Google Scholar 

Hazlett EA, Rothstein EG, Ferreira R, Silverman JM, Siever LJ, Olincy A (2015) Sensory gating disturbances in the spectrum: Similarities and differences in schizotypal personality disorder and schizophrenia. Schizophr Res 161:283–290

Article  PubMed  Google Scholar 

Lijffijt M, Moeller FG, Boutros NN, Burroughs S, Steinberg JL, Lane SD, Swann AC (2009) A pilot study revealing impaired p50 gating in antisocial personality disorder. J Neuropsychiatry Clin Neurosci 21:328–331

Article  PubMed  PubMed Central  Google Scholar 

Tan SP, Jie-Feng C, Fan FM, Zhao YL, Chen N, Fan HZ, Zhang JG, Wang YH, Yoon JH, Soares JC, Zou YZ, Zhang XY (2014) Smoking, matrics consensus cognitive battery and p50 sensory gating in a han chinese population. Drug Alcohol Depend 143:51–57

Article  PubMed  Google Scholar 

Ocklenburg S, Westerhausen R, Hirnstein M, Hugdahl K (2013) Auditory hallucinations and reduced language lateralization in schizophrenia: a meta-analysis of dichotic listening studies. J Int Neuropsychol Soc 19:410–418

Article  PubMed  Google Scholar 

Vuillier L, Hermens DF, Chitty K, Wang C, Kaur M, Ward PB, Degabriele R, Hickie IB, Lagopoulos J (2015) Emotional processing, p50 sensory gating, and social functioning in bipolar disorder. Clin EEG Neurosci 46:81–87

Article  PubMed  Google Scholar 

Buckley PE, Evans D (2006) First-episode schizophrenia. A window of opportunity for optimizing care and outcomes. Postgraduate Medicine Spec No: 5–19

Luo Y, Zhang J, Wang C, Zhao X, Chang Q, Wang H, Wang C (2019) Discriminating schizophrenia disease progression using a p50 sensory gating task with dense-array eeg, clinical assessments, and cognitive tests. Expert Rev Neurother 19:459–470

Article  CAS  PubMed  Google Scholar 

Bachmann S, Weisbrod M, Röhrig M, Schröder J, Thomas C, Scherg M, Rupp A (2010) Meg does not reveal impaired sensory gating in first-episode schizophrenia. Schizophr Res 121:131–138

Article  PubMed  Google Scholar 

Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR (2008) The matrics consensus cognitive battery, part 2: Co-norming and standardization. Am J Psychiatry 165:214–220

Article  PubMed  Google Scholar 

Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR (2008) The matrics consensus cognitive battery, part 1: Test selection, reliability, and validity. Am J Psychiatry 165:203–213

Article  PubMed  Google Scholar 

Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R (2009) Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the third CNTRICS meeting. Schizophr Bull 35:109–114

Zhang X, Yang M, Du X, Liao W, Chen D, Fan F, Xiu M, Jia Q, Ning Y, Huang X, Wu F, Soares JC, Cao B, Wang L, Chen H (2019) Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia. Mol Psychiatry. https://doi.org/10.1038/s41380-019-0478-1

Article  PubMed  PubMed Central  Google Scholar 

Wu JQ, Chen DC, Tan YL, Xiu MH, De YF, Soares JC, Zhang XY (2016) Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: matrics consensus cognitive battery in a chinese han population. Psychiatry Res 238:196–202

Article  PubMed  Google Scholar 

Cui JF, Zou YZ, Li Y, Wang J, Chen N, Fan HZ, Zhang D, Xu Z, Song SG, Wang YH, Gao WJ, Duan JH (2009) Reliability and validity of brief assessment of cognition in schizophrenia. Chin Ment Health J 23(3):183–187

Google Scholar 

Cui JF, Zou YZ, Wang J, Chen N, Fan HZ, Yao J, Duan JH (2012) Reliability and validity of the ucsd performance-based skills assessment-brief. Chin Ment Health J 26:577–583

Google Scholar 

Tan S, Zhu X, Fan H, Tan Y, Yang F, Wang Z, Zhao Y, Fan F, Guo J, Li Z, Quan W, Wang X, Reeder C, Zhou D, Zou Y, Wykes T (2019) Who will benefit from computerized cognitive remediation therapy? Evidence from a multisite randomized controlled study in schizophrenia. Psychol Med 50(10):1633–1643

Article  PubMed  PubMed Central  Google Scholar 

Hamilton HK, Williams TJ, Ventura J, Jasperse LJ, Owens EM, Miller GA, Subotnik KL, Nuechterlein KH, Yee CM (2018) Clinical and cognitive significance of auditory sensory processing deficits in schizophrenia. Am J Psychiatry 175:275–283

Article  PubMed  Google Scholar 

Sánchezmorla EM, Santos JL, Aparicio A, Garcíajiménez MÁ, Soria C, Arango C (2013) Neuropsychological correlates of p50 sensory gating in patients with schizophrenia. Schizophr Res 143:102–106

Article  PubMed  Google Scholar 

Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Okumura M, Otsuka T, Nakayama K, Halldin C, Farde L, Suhara T (2011) Effect of risperidone on high-affinity state of dopamine d2 receptors: A pet study with agonist ligand [11c](r)-2-ch3o-n-n-propylnorapomorphine. Int J Neuropsychopharmacol 14:83–89

Article  CAS  PubMed